Waldencast reports Q2 results; updates FY outlook

* Waldencast press release [https://seekingalpha.com/pr/20317944-waldencast-announces-q2-2025-results-and-provides-q3-2025-trading-update] (WALD [https://seekingalpha.com/symbol/WALD]): Q2 Revenue of $66.83M (+5.6% Y/Y) beats by $0.18M.
*
Outlook

"Our updated full-year outlook reflects Obagi Medical's performance in line with expectations and incorporates a moderated view for Milk Makeup due to softer consumption and continued investment to position the brand for future success. As a result, we now expect net revenue to be broadly in line with 2024 and Adjusted EBITDA Margin in the high single digits.”

MORE ON WALDENCAST

* Waldencast: Fairly Valued With Ulta Lift Already Reflected, Saypha Deal Adds Optionality [https://seekingalpha.com/article/4824986-waldencast-stock-fairly-valued-ulta-lift-already-reflected-saypha-deal-adds-optionality]
* Seeking Alpha’s Quant Rating on Waldencast [https://seekingalpha.com/symbol/WALD/ratings/quant-ratings]
* Historical earnings data for Waldencast [https://seekingalpha.com/symbol/WALD/earnings]
* Financial information for Waldencast [https://seekingalpha.com/symbol/WALD/income-statement]